Home Print E-mail

Melissa Gilmore

Associate

DC Office
701 Eighth Street, NW, Suite 410
Washington, DC 20001
gilmore@clm.com
phone: 202-898-1515
fax: 202-898-1521 download v-card

Practice Areas

Litigation, Food, Drug, and Medical Device, Environmental, Washington Office

Practice Description

Food and drug law, business and contract disputes, commercial litigation, environmental law.

Education

  • A.B., 1991 Duke University (cum laude; Dean's List with Distinction, Chair, University Ethics Committee, President's Student Leadership Conference)
  • J.D., 1996 Georgetown University Law Center (cum laude; Senior Staff Editor, Georgetown Journal of Legal Ethics, Dean's List, Teagle Foundation Academic Scholarship)

Admissions

  • 1997 District of Columbia
  • 1997 New York
  • 2000 Washington
  • 2002 California

Publications Available on this website...

"Compliance Race: New FDA Dietary Supplement Rule Takes Effect," Client Advisory, September 7, 2007

Additional Publications

“The Case Against Advocates' Immunity: A Comparative Study,” 9 Georgetown Journal of Legal Ethics 267, 1995; “International Benchmarking,” Competitive Intelligence Review, Vol. 3 No. 2, 1992 (co-authored)

Illustrative Matters

  • Representation of foreign manufacturer and distributor of medical devices in connection with several PMA supplements and IDEs for significant risk devices.
  • Representation of manufacturers of dietary supplements in FDA reviews and approvals.
  • Negotiation of agreements on behalf of medical device manufacturers to conduct clinical studies.
  • Consultation by foreign medical device manufacturer and distributor on potential acquisition of U.S. medical device company.
  • Due diligence targeting FDA regulatory matters in connection with potential corporate acquisitions.
  • Representation of publicly-traded biopharmaceutical company that acquires, develops, and commercializes innovative products to advance cancer care.
  • Representation of a leading global financial services firm in connection with lending to a publicly-traded biopharmaceutical company.
  • Representation of employers involved in non-competition contract issues.
  • Representation of individual property owner in dispute over new construction in federally-protected historic district of Georgetown in Washington, DC.
  • Representation of landowners in case against large chemical company accused of poisoning livestock.
  • Representation of company with buildings damaged in Hurricane Katrina in insurance coverage dispute.
  • Representation of government entity in redevelopment and other activities along Anacostia River in Washington, DC.
  • Representation of government entity and memorial foundation with World Trade Center deconstruction and redevelopment efforts in Lower Manhattan.
  • Representation of clients in other areas of environmental practice such as wetlands, environmental cleanup liability contracts, and environmental insurance coverage issues.